Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.

The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at ...

The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed ...

J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the ...

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts questioned the value of a fully autonomous robot.

The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...

The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...

Glucotrack, which is developing a glucose monitor that is implanted through a minimally invasive surgery, said the small ...

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

The purchase of the Providence spinoff bolsters Samsung’s push to unify health data, including through wearables like the ...